about
The ongoing challenge of latent tuberculosisManagement of Suspected Avian (H5N1) Influenza in a Non-pandemic Setting.Cardio-Thoracic Ratio Is Stable, Reproducible and Has Potential as a Screening Tool for HIV-1 Related Cardiac Disorders in Resource Poor Settings.QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response.Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies.Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography.Minimizing Tuberculosis Risk in Patients Receiving Anti-TNF Therapy.Tuberculosis is changing.From latent to patent: rethinking prediction of tuberculosis.Is MRSA admission bacteraemia community-acquired? A case control study.Tuberculosis Infectiousness and Host Susceptibility.Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis.Detection and treatment of subclinical tuberculosisReactivation or re-infection? [Correspondence]Extensive myofascial necrosis: A delayed complication of botulinum toxin therapyTranscriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
P50
Q28386135-C45F354C-F8FE-4132-BEDD-4A87613BE00EQ30403107-8497B0D1-334D-4B2E-A724-51184A39B38DQ36152663-2F8F81F1-D6EE-4452-9ECB-B5885A2D5D24Q36157985-BACE6D89-6B31-4BFC-A56A-DEED8D5D84E9Q36238015-A8670819-4752-48DF-84F1-490E808BD460Q36287555-46B9D301-6AC0-4BE7-8CB1-EFF24CEE0BC5Q37322344-477567C1-0DB6-498E-820C-164F50FE786BQ40231325-A6F4EB9F-37D2-4D03-BB20-9A9F1A1B7063Q40292734-07239EDA-FEDB-4F2A-B13D-3B6B7275FCB6Q40395992-FD0180CF-6B05-4541-BC00-7138DFB4B137Q44468731-B003E93D-5645-41D1-9AE7-4AD2ABC990B2Q47720001-304619B1-8956-49D5-9265-17E9FBBCA9B6Q48232204-B08B5B08-F289-4B30-8419-221560A4C84DQ57598533-39CB8274-B721-48E7-9C38-58C8FBFE39E6Q60364610-F67DFA9D-9EAF-46D4-9342-66E234A8611EQ60364611-BED162DD-1DBD-4D30-8278-1B7F7443D455Q92711393-8AEE12FD-81DE-45AA-8759-F1B687B4F377
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hanif Esmail
@ast
Hanif Esmail
@en
Hanif Esmail
@es
Hanif Esmail
@nl
type
label
Hanif Esmail
@ast
Hanif Esmail
@en
Hanif Esmail
@es
Hanif Esmail
@nl
prefLabel
Hanif Esmail
@ast
Hanif Esmail
@en
Hanif Esmail
@es
Hanif Esmail
@nl
P106
P21
P31
P496
0000-0002-4278-9316